Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.The company was founded in 2001 and headquartered in Marlborough, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 28, 2020 | Series Unknown | $2.60M | 1 | — | — | Detail |
Oct 22, 2008 | Series B | $18.50M | 1 | — | — | Detail |
Jan 23, 2006 | Angel | $500K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Sidecar Fund2 | — | Series Unknown |
Rockport Venture Partners | — | Series B |
Granite State Angels | — | Angel |